Trial of a New Online Programme for Physical Activity and Healthy Eating.

March 15, 2019 updated by: Elisabeth Grey, University of Bath

Trial of a Self-directed Behaviour Change Intervention for Physical Activity and Healthy Eating.

Many healthy lifestyle interventions have been developed to help people change their activity and diet, lose weight and thus reduce their risk of developing type 2 diabetes (T2DM) and cardiovascular disorders (CVD). However, these interventions often fail to engage their target audience, which undermines their effectiveness in changing behaviour and health outcomes.

The purpose of this study is to investigate the effectiveness of a self-directed, website-based intervention to promote physical activity and healthy dietary behaviours. The intervention frames health information from a novel perspective, which our previous work has indicated can help to promote interest in the health information and improve attitudes, self-efficacy and motivation towards physical activity and healthy dietary behaviours.

The intervention comprises a website of information resources and personal recording areas to set goals and monitor activity and diet, weekly emails and pedometers. In this trial we aim to see whether the intervention has any impact on people's physical activity and diet, as well as their risk of developing CVD and T2DM. The intervention will be compared with a control condition in which participants will be shown standard resources available on NHS websites. Overweight/obese (BMI 25 - 39.5) males and females aged 35-74 years will be recruited from the community. The active intervention will last 6 weeks (during this period participants will receive weekly emails from the research team) and there will be a 6-week follow-up phase (in which participants will still have access to the website but contact from the research team). Activity, diet, disease risk markers and psychological antecedents of behaviour will be assessed at baseline, post-intervention (6-weeks) and post follow-up (12- weeks).

Study Overview

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 74 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Able to give informed consent to participate in the study.
  • Male or female and aged between 35-74 years.
  • Defined as overweight or obese, i.e. BMI>25kg/m2.
  • Able to travel to the university for assessment days.

Exclusion Criteria:

  • Individuals who are not fluent in the English language, and who do not have access to and do not regularly use the internet and an email account.
  • Individuals diagnosed with coronary heart disease, chronic kidney disease, type 2 diabetes, stroke, heart failure, severe hypertension (BP>180/110mmHg) and peripheral arterial disease.
  • BMI>40kg/m2 (morbidly obese).
  • Currently using weight loss drugs or other medication that can affect weight.
  • Any reported recent (i.e. last 6 months) shift (>5%) in body mass or large change in habitual lifestyle.
  • Individuals unable to change their physical activity (e.g. through disability).
  • Current (pre-baseline) or recent (i.e. last 2 months) participation in another research trial or lifestyle supportive intervention or referral.
  • Pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Website and pedometer Intervention
Participants allocated to this group will be given a one-off set-up session in which a researcher will show them the intervention website, create a user profile for them and provide guidance on how to use the site to gain health information, set personal behavioural goals and record and monitor their behaviour in relation to their goals. The researcher will also provide the participant with a pedometer and instruct them how to use this and where they can record their daily steps on the website. For 6 weeks, participants will be asked to use the website and be sent weekly email reminders to do so and log their goal progress. After 6 weeks, no further emails will be sent but participants will still be able to access the website and use the pedometer if they wish.
Self-directed, website-based intervention delivered with a pedometer to promote understanding of health and health behaviour change.
Other: Control
Participants allocated to this group will be given a one-off session in which a researcher shows them publicly available web-based resources for health behaviour change (provided by the National Health Service (NHS)). Like those participants in the intervention group, they will be assessed again after 6 and 12 weeks. Participants in the control arm will be offered the intervention (access to the study website and a pedometer) after 12 weeks.
Standard, publicly available NHS resources for healthy lifestyles.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in mean daily physical activity level (PAL)
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Mean daily physical activity level (PAL) will be assessed using accelerometers (BodyMedia, worn on the upper arm), worn for a continuous 7-day period, being removed during this time only for water-based activities such as showering or swimming. The accelerometers gather minute by minute total energy expenditure (TEE) data, which will be used to calculate PAL (PAL = TEE/BMR, where BMR = basal metabolic rate, to be calculated using the Schofield equation).
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Change in mean daily energy intake (EI)
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Mean daily energy intake (EI) will be assessed using 3-day weighed food diaries, incorporating 2 week days and 1 weekend day .
Baseline, 6 weeks and 12 weeks after starting the intervention/control period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fasting plasma glucose concentration
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Comparison of glucose concentration in the blood plasma at rest across all three measurement points.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Fasting plasma insulin concentration
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Comparison of insulin concentration in the blood plasma at rest across all three measurement points.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Fasting triglyceride concentration
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Comparison of triglyceride concentration in the blood serum at rest across all three measurement points.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Fasting total cholesterol concentration
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Comparison of total concentration in the blood serum at rest across all three measurement points.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Fasting LDL cholesterol concentration
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Comparison of LDL concentration in the blood serum at rest across all three measurement points.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Fasting HDL cholesterol concentration
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Comparison of HDL concentration in the blood serum at rest across all three measurement points.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
C-reactive protein (CRP) concentration
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Comparison of CRP concentration in the blood serum at rest across all three measurement points.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Body mass index (BMI)
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Comparison of BMI (defined as mass in kg divided by height in metres squared) across all three measurement points.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Waist circumference
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Comparison of waist circumference (in centimetres) across all three measurement points.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Blood pressure
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Comparison of blood pressure (systolic/diastolic mmHG) across all three measurement points.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Quality of diet
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Diet quality will be assessed based on the proportion of fibre, free sugars and refined carbohydrates, and saturated fats in the diet. The intervention aims to promote an increase in fibre intake and decrease in free sugar, refined carbohydrate and saturated fat intake. Data will be collected using 3-day weighed food diaries, incorporating 2 week days and 1 weekend day.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Motivation for physical activity
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Motivation will be assessed using the Behavioural Regulation for Exercise Questionnaire 3 (BREQ 3: Markland & Tobin, 2004; Wilson, Rodgers, Loitz & Scime, 2006) adapted for physical activity.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Motivation for healthy eating
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Motivation will be assessed using the Behavioural Regulation for Exercise Questionnaire 3 (BREQ 3: Markland & Tobin, 2004; Wilson, Rodgers, Loitz & Scime, 2006) adapted for diet.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Self-efficacy for physical activity and healthy eating
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Self-efficacy will be measured using the Barriers Self-Efficacy Scale for Exercise (BARSE; McAuley, 1992) adapted for physical activity.
Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Self-efficacy for healthy eating
Time Frame: Baseline, 6 weeks and 12 weeks after starting the intervention/control period
Self-efficacy will be measured using the self-efficacy scale for eating a healthy diet developed by Pawlak and Colby (2009).
Baseline, 6 weeks and 12 weeks after starting the intervention/control period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dylan Thompson, PhD, University of Bath

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 16, 2017

Primary Completion (Actual)

September 12, 2017

Study Completion (Actual)

September 12, 2017

Study Registration Dates

First Submitted

January 19, 2017

First Submitted That Met QC Criteria

January 23, 2017

First Posted (Estimate)

January 26, 2017

Study Record Updates

Last Update Posted (Actual)

March 19, 2019

Last Update Submitted That Met QC Criteria

March 15, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EP 16/17 034

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight/Obesity

Clinical Trials on Website and pedometer intervention

3
Subscribe